95
Participants
Start Date
June 30, 2006
Primary Completion Date
December 31, 2009
Study Completion Date
July 31, 2010
Picoplatin
"The treatment regimen will be the assigned dose of picoplatin plus docetaxel, 60 mg/m2 or 75 mg/m2, once every three weeks, plus prednisone (or prednisolone, if prednisone is not available), 5 mg orally twice daily beginning on day 1 and continuing daily until therapy is discontinued.~Docetaxel will be given intravenously over 60 minutes, followed 30 minutes later by picoplatin as a 1-2 hour intravenous infusion."
docetaxel
"The treatment regimen will be the assigned dose of picoplatin plus docetaxel, 60 mg/m2 or 75 mg/m2, once every three weeks, plus prednisone (or prednisolone, if prednisone is not available), 5 mg orally twice daily beginning on day 1 and continuing daily until therapy is discontinued.~Docetaxel will be given intravenously over 60 minutes, followed 30 minutes later by picoplatin as a 1-2 hour intravenous infusion."
Burdenko Central Military Clinical Hospital, Moscow
Russian Research Center of Radiology, Moscow
State Medical Institution of Yaroslavl Region / Regional Clinical Oncology Hospital, Yaroslavl
Leningrad Regional Oncology Center, Saint Petersburg
Central Medical Unit #122, Saint Petersburg
Therapeutic and Research Medical Center, Saint Petersburg
St. Petersburg City Hospital #26, Saint Petersburg
St. Petersburg City Oncology Center, Saint Petersburg
Medical Radiology Research Center under the Russian Academy of Medical Sciences, Obninsk
Chelyabinsk Regional Oncology Center, Chelyabinsk
Research Institute of Urology - Ministry of Health, Moscow
Lead Sponsor
Poniard Pharmaceuticals
INDUSTRY